These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 31993365)
1. Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors. Hernández de la Cruz ON; López-González JS; García-Vázquez R; Salinas-Vera YM; Muñiz-Lino MA; Aguilar-Cazares D; López-Camarillo C; Carlos-Reyes Á Front Oncol; 2019; 9():1419. PubMed ID: 31993365 [TBL] [Abstract][Full Text] [Related]
2. Vasculogenic mimicry in carcinogenesis and clinical applications. Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087 [TBL] [Abstract][Full Text] [Related]
3. Functional roles of microRNAs in vasculogenic mimicry and resistance to therapy in human cancers: an update. García-Hernández AP; Sánchez-Sánchez G; Carlos-Reyes A; López-Camarillo C Expert Rev Clin Immunol; 2024 Aug; 20(8):913-926. PubMed ID: 38712535 [TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry. Zhang X; Zhang J; Zhou H; Fan G; Li Q J Cancer; 2019; 10(25):6327-6340. PubMed ID: 31772665 [TBL] [Abstract][Full Text] [Related]
5. Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma. Ren K; Ni Y; Li X; Wang C; Chang Q; Li Y; Gao Z; Wu S; Shi X; Song J; Yao N; Zhou J J Cell Biochem; 2019 Aug; 120(8):12473-12488. PubMed ID: 30825232 [TBL] [Abstract][Full Text] [Related]
6. An Overview of Vasculogenic Mimicry in Breast Cancer. Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J Front Oncol; 2020; 10():220. PubMed ID: 32175277 [TBL] [Abstract][Full Text] [Related]
7. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Sun B; Zhang D; Zhao N; Zhao X Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014 [TBL] [Abstract][Full Text] [Related]
8. Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets. Tang H; Chen L; Liu X; Zeng S; Tan H; Chen G Front Pharmacol; 2024; 15():1346719. PubMed ID: 38694917 [TBL] [Abstract][Full Text] [Related]
9. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy. Fan YZ; Sun W World J Gastrointest Surg; 2010 Apr; 2(4):117-27. PubMed ID: 21160860 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells. Aikins AR; Kim M; Raymundo B; Kim CW Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Vasculogenic Mimicry in Ovarian Cancer. Ayala-Domínguez L; Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Manzo-Merino J; Martínez-Ramírez I; Lizano M Front Oncol; 2019; 9():998. PubMed ID: 31612116 [TBL] [Abstract][Full Text] [Related]
13. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718 [TBL] [Abstract][Full Text] [Related]
14. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974 [TBL] [Abstract][Full Text] [Related]
15. Vasculogenic Mimicry in Breast Cancer: Clinical Relevance and Drivers. Morales-Guadarrama G; García-Becerra R; Méndez-Pérez EA; García-Quiroz J; Avila E; Díaz L Cells; 2021 Jul; 10(7):. PubMed ID: 34359928 [TBL] [Abstract][Full Text] [Related]
16. Overview of advances in vasculogenic mimicry - a potential target for tumor therapy. Ge H; Luo H Cancer Manag Res; 2018; 10():2429-2437. PubMed ID: 30122992 [TBL] [Abstract][Full Text] [Related]
17. Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas. Sun B; Zhang S; Zhao X; Zhang W; Hao X Int J Oncol; 2004 Dec; 25(6):1609-14. PubMed ID: 15547697 [TBL] [Abstract][Full Text] [Related]